{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&houseId=1&tablingMemberConstituency=Newcastle-under-Lyme", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&houseId=1&tablingMemberConstituency=Newcastle-under-Lyme", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&houseId=1&tablingMemberConstituency=Newcastle-under-Lyme&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=0&houseId=1&tablingMemberConstituency=Newcastle-under-Lyme", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&houseId=1&tablingMemberConstituency=Newcastle-under-Lyme", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&houseId=1&tablingMemberConstituency=Newcastle-under-Lyme", "items" : [{"_about" : "http://data.parliament.uk/resources/1728222", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1728222/answer", "answerText" : {"_value" : "<p>We are committed to improving sexual heath in England for the whole population, and are currently considering the next steps in doing so. My Rt hon. Friend, the Secretary of State for Health and Social Care has commissioned officials for advice on how to progress the development of a new HIV Action Plan, which we aim to publish by summer 2025.<\/p><p>The Government is also committed to prioritising women's health as we build a National Health Service fit for the future. We are considering how to take forward the Women's Health Strategy for England.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
        }
        , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
        , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
        , "dateOfAnswer" : {"_value" : "2024-09-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-09-12T15:22:52.28Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-09-09", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Genito-urinary Medicine"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of creating a new Sexual Health Strategy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "4790"}
    , {"_about" : "http://data.parliament.uk/resources/1728258", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1728258/answer", "answerText" : {"_value" : "<p>Screening for prostate cancer is currently not recommended by the UK National Screening Committees (UK NSC). This is because of the inaccuracy of the current best test, the Prostate Specific Antigen (PSA). A PSA-based screening programme could harm men, as some of them would be diagnosed with a cancer that would not have caused them problems during their life. This would lead to additional tests and treatments which can also have harmful side effects.<\/p><p>The UK NSC is currently carrying out an evidence review for prostate cancer screening, which includes different potential ways of screening the whole population from 40 years of age onwards, and targeted screening programme aimed at groups of men identified as being at higher than average risk, such as those with a family history, carriers of the BRCA2 gene, or based on ethnicity.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
        }
        , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
        , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
        , "dateOfAnswer" : {"_value" : "2024-09-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-09-12T15:18:31.43Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-09-09", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prostate Cancer: Screening"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential benefits of introducing national screening for prostate cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "4826"}
    , {"_about" : "http://data.parliament.uk/resources/1726832", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1726832/answer", "answerText" : {"_value" : "<p>Palliative care services are included in the list of services an integrated care board (ICB), including the Staffordshire and Stoke-on-Trent ICB, which covers Newcastle-under-Lyme, must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care.\u202fTo support the ICBs in this duty, NHS England has published statutory guidance\u202fand\u202fservice specifications.<\/p><p>Whilst the majority of palliative and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people, and their loved ones, at the end of life.<\/p><p>Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding charitable hospices receive varies by ICB area, and will, in part, be dependent on the breadth and range of palliative and end of life care provision within their ICB footprint.<\/p><p>We understand that, financially, times are difficult for many voluntary and charitable organisations, including hospices, due to the increased cost of living. We want a society where these costs are manageable for both voluntary organisations, like hospices, and the people whom they serve.<\/p><p>We, alongside NHS England, will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, in order to understand the issues they face.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4359", "label" : {"_value" : "Biography information for Stephen Kinnock"}
        }
        , "answeringMemberConstituency" : {"_value" : "Aberafan Maesteg"}
        , "answeringMemberPrinted" : {"_value" : "Stephen Kinnock"}
        , "dateOfAnswer" : {"_value" : "2024-09-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-09-10T11:01:52.58Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-09-02", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hospices: Newcastle-under-Lyme"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the (a) provision and (b) funding of hospice care in Newcastle-under-Lyme constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "3883"}
    , {"_about" : "http://data.parliament.uk/resources/1726054", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1726054/answer", "answerText" : {"_value" : "<p>We will get the National Health Service catching cancer on time, diagnosing it earlier and treating it faster so more patients survive this horrible set of diseases, including bladder cancer, and we will improve patients\u2019 experience across the system.<\/p><p>Nationally, there is a focus on innovation and a move to develop new cancer tests. University Hospitals of North Midlands (UHNM) NHS Trust has been part of the Galleri trial of blood tests to identify cancer at the earliest stage. The trust is supporting the development of these trials and their adoptions as they are made available.<\/p><p>UHNM is working with primary care networks and other primary care stakeholders to outline a clear set of actions and milestones to improve referral practice, particularly for bowel, gynaecology and urology patients.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bristol South"}
        , "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
        , "dateOfAnswer" : {"_value" : "2024-09-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-09-10T11:26:18.937Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-08-30", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Bladder Cancer: Newcastle-under-Lyme"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he has taken to help ensure that people with bladder cancer in Newcastle-under-Lyme constituency receive (a) an early diagnosis and (b) swift treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "3451"}
    , {"_about" : "http://data.parliament.uk/resources/1726055", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1726055/answer", "answerText" : {"_value" : "<p>NHS England\u2019s RightCare toolkit and Getting It Right First Time programme aim to improve care for people with Parkinson\u2019s disease by reducing variation and delivering care more equitably across the country.<\/p><p>The National Institute for Health and Care Excellence\u2019s (NICE) guidance, Parkinson\u2019s disease: Diagnosis and management in primary and secondary care, updated in 2017, sets out best practice for clinicians in the identification and treatment of Parkinson\u2019s, in line with the latest available evidence. The guidance states that if Parkinson's is suspected, people should be referred quickly and untreated to a specialist with expertise in the differential diagnosis of this condition.<\/p><p>There are 27 specialised neurological treatment centres across the National Health Service in England, with the nearest to Newcastle-under-Lyme being in the University Hospitals of North Midlands, which provide access to neurological multidisciplinary teams to ensure that patients with Parkinson\u2019s can receive specialised treatment and support, according to their needs.<\/p><p>We expect integrated care boards (ICBs) and NHS trusts to have due regard to relevant NICE guidelines. It is the responsibility of the ICBs, including the Staffordshire and Stoke-on-Trent ICB which covers Newcastle-under-Lyme, to make available appropriate provision to meet the health and care needs of their local population, in line with these NICE guidelines, including diagnosis and treatment.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
        }
        , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
        , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
        , "dateOfAnswer" : {"_value" : "2024-09-05", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-09-05T09:55:07.197Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-08-30", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Parkinson's Disease: Newcastle-under-Lyme"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he has taken to help ensure that people with Parkinson\u2019s in Newcastle-under-Lyme constituency receive (a) an early diagnosis and (b) swift treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "3452"}
    , {"_about" : "http://data.parliament.uk/resources/1726058", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1726058/answer", "answerText" : {"_value" : "<p>Whilst we have made no specific assessment, the clinical trial evidence considered by the National Institute for Health and Care Excellence (NICE) shows that Enhertu increases how long people live and how long they have before their cancer gets worse compared with chemotherapy treatments used for HER2\u2011negative breast cancer. It is not, however, a curative treatment.<\/p><p>We understand from NICE that it is estimated that approximately 1,000 women in England would have been eligible for treatment with Enhertu, if NICE had been able to recommend it for use in the treatment of HER2-low breast cancer. Information at constituency level is not held.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bristol South"}
        , "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
        , "dateOfAnswer" : {"_value" : "2024-09-09", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-09-09T10:46:15.993Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-08-30", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Trastuzumab Deruxtecan"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of Enhertu in reducing the number of women who lose their lives to breast cancer in (a) Newcastle-under-Lyme constituency and b) England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "3455"}
    , {"_about" : "http://data.parliament.uk/resources/1726137", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1726137/answer", "answerText" : {"_value" : "<p>The National Institute for Health and Care Excellence (NICE) published guidance recommending foslevodopa\u2013foscarbidopa (Produodopa) for patients with Parkinson\u2019s disease meeting specified clinical criteria, in November 2023. Produodopa is now available to eligible National Health Service patients in England, including in Newcastle-Under Lyme, in line with the NICE\u2019s recommendations.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bristol South"}
        , "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
        , "dateOfAnswer" : {"_value" : "2024-09-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "3460"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-09-09T09:34:10.917Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-08-30", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Parkinson's Disease: Newcastle-under-Lyme"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of procuring Produodopa via the NHS on the treatment of Parkinson's disease in Newcastle-Under Lyme constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "3459"}
    , {"_about" : "http://data.parliament.uk/resources/1726138", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1726138/answer", "answerText" : {"_value" : "<p>The National Institute for Health and Care Excellence (NICE) published guidance recommending foslevodopa\u2013foscarbidopa (Produodopa) for patients with Parkinson\u2019s disease meeting specified clinical criteria, in November 2023. Produodopa is now available to eligible National Health Service patients in England, including in Newcastle-Under Lyme, in line with the NICE\u2019s recommendations.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bristol South"}
        , "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
        , "dateOfAnswer" : {"_value" : "2024-09-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "3459"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-09-09T09:34:10.947Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-08-30", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Parkinson's Disease: Newcastle-under-Lyme"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will take steps to increase the availability of Produodopa for people with Parkinson\u2019s disease in Newcastle-under-Lyme constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "3460"}
    , {"_about" : "http://data.parliament.uk/resources/1722639", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1722639/answer", "answerText" : {"_value" : "<p>The Government plans to tackle the challenges patients face when trying to access National Health Service dental care with a rescue plan to provide 700,000 more urgent dental appointments and recruit new dentists to the areas that need them most. To rebuild dentistry in the long term and increase access to NHS dental care, we will reform the dental contract, with a shift to focus on prevention and the retention of NHS dentists.<\/p><p>From 1 April 2023, the responsibility for commissioning primary care dentistry to meet the needs of the local population has been delegated to all integrated care boards across England.<\/p><p>NHS dentists are required to keep their NHS.UK profiles up to date so that patients can find a dentist more easily. This includes information on whether they are accepting new patients. In circumstances where patients are unable to access an urgent dental appointment directly through an NHS dental practice, they should contact NHS 111.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4359", "label" : {"_value" : "Biography information for Stephen Kinnock"}
        }
        , "answeringMemberConstituency" : {"_value" : "Aberafan Maesteg"}
        , "answeringMemberPrinted" : {"_value" : "Stephen Kinnock"}
        , "dateOfAnswer" : {"_value" : "2024-07-30", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-07-30T10:41:10.887Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-07-22", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Dental Services: Newcastle-under-Lyme"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he plans to take to help improve access to NHS dentistry in Newcastle-under-Lyme constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "1086"}
    , {"_about" : "http://data.parliament.uk/resources/1722642", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1722642/answer", "answerText" : {"_value" : "<p>It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including autism assessment services, in line with National Institute for Health and Care Excellence guidelines.<\/p><p>On 5 April 2023, NHS England published a national framework and operational guidance to deliver improved outcomes in all-age autism assessment pathways. This guidance will help ICBs and the National Health Service to deliver improved outcomes for children, young people, and adults referred to an autism assessment service.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4359", "label" : {"_value" : "Biography information for Stephen Kinnock"}
        }
        , "answeringMemberConstituency" : {"_value" : "Aberafan Maesteg"}
        , "answeringMemberPrinted" : {"_value" : "Stephen Kinnock"}
        , "dateOfAnswer" : {"_value" : "2024-07-31", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-07-31T14:07:48.643Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-07-22", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Autism: Newcastle-under-Lyme"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the process to secure an autism diagnosis for children living in Newcastle-under-Lyme constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : "http://data.parliament.uk/members/5168", "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
      , "tablingMemberPrinted" : [{"_value" : "Adam Jogee"}
      ], "uin" : "1089"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=1&houseId=1&tablingMemberConstituency=Newcastle-under-Lyme", "page" : 0, "startIndex" : 1, "totalResults" : 164, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}